{
  "id": 5344850,
  "title": "Fighting cancer with cancer: new vaccine raises hope",
  "url": "https://urgent.news/2026/09/03/fighting-cancer-with-cancer-new-vaccine-raises-hope",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-03T14:10:56.000Z",
  "source": {
    "name": "Al Majalla English",
    "slug": "al-majalla-english",
    "url": "https://en.majalla.com/node/332865/science-technology/fighting-cancer-cancer-new-vaccine-raises-hope"
  },
  "original_language": "en",
  "account": "Recent clinical trials of a personalized cancer vaccine have sparked optimism in the medical community. Developed by pharmaceutical giants Moderna and Merck, the vaccine employs a patient's own tumor genetic material to train the immune system to target residual malignant cells post-surgery. The announcement of the first-ever positive results from a Phase III trial occurred on August 19, 2025, signaling a potential breakthrough in treating high-risk melanoma, a prevalent form of skin cancer. The vaccine relies on neoantigens, unique proteins formed due to cancer-specific DNA mutations. While the treatment remains experimental and not yet approved, oncologists are enthusiastic about its potential as a transformative cancer therapy.",
  "summary": "Fighting cancer with cancer: new vaccine raises hope newspress_en Thu, 09/03/2026 - 15:10 Science & Technology Last month, two major pharmaceutical companies released cancer drug trial results that excited oncologists. The results showed that a vaccine can be designed from the genetic features of a patient’s own tumour and used to train their immune system to hunt down any malignant cells still…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}